Literature DB >> 23979601

Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling.

Victoria A McGuire1, Alexander Gray, Claire E Monk, Susana G Santos, Keunwook Lee, Anna Aubareda, Jonathan Crowe, Natalia Ronkina, Jessica Schwermann, Ian H Batty, Nick R Leslie, Jonathan L E Dean, Stephen J O'Keefe, Mark Boothby, Matthias Gaestel, J Simon C Arthur.   

Abstract

The stimulation of Toll-like receptors (TLRs) on macrophages by pathogen-associated molecular patterns (PAMPs) results in the activation of intracellular signaling pathways that are required for initiating a host immune response. Both phosphatidylinositol 3-kinase (PI3K)-Akt and p38 mitogen-activated protein kinase (MAPK) signaling pathways are activated rapidly in response to TLR activation and are required to coordinate effective host responses to pathogen invasion. In this study, we analyzed the role of the p38-dependent kinases MK2/3 in the activation of Akt and show that lipopolysaccharide (LPS)-induced phosphorylation of Akt on Thr308 and Ser473 requires p38α and MK2/3. In cells treated with p38 inhibitors or an MK2/3 inhibitor, phosphorylation of Akt on Ser473 and Thr308 is reduced and Akt activity is inhibited. Furthermore, BMDMs deficient in MK2/3 display greatly reduced phosphorylation of Ser473 and Thr308 following TLR stimulation. However, MK2/3 do not directly phosphorylate Akt in macrophages but act upstream of PDK1 and mTORC2 to regulate Akt phosphorylation. Akt is recruited to phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the membrane, where it is activated by PDK1 and mTORC2. Analysis of lipid levels in MK2/3-deficient bone marrow-derived macrophages (BMDMs) revealed a role for MK2/3 in regulating Akt activity by affecting availability of PIP3 at the membrane. These data describe a novel role for p38α-MK2/3 in regulating TLR-induced Akt activation in macrophages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979601      PMCID: PMC3811899          DOI: 10.1128/MCB.01691-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

1.  The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.

Authors:  David Torres; Sandrine Delbauve; Ezra Aksoy; Salma Taboubi; Abderrahman Hachani; Maria A Whitehead; Wayne P Pearce; Inma M Berenjeno; Gemma Nock; Alain Filloux; Rudi Beyaert; Veronique Flamand; Bart Vanhaesebroeck
Journal:  Nat Immunol       Date:  2012-09-30       Impact factor: 25.606

2.  The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation.

Authors:  Andrew E Gelman; David F LaRosa; Jidong Zhang; Patrick T Walsh; Yongwon Choi; J Oriol Sunyer; Laurence A Turka
Journal:  Immunity       Date:  2006-10-19       Impact factor: 31.745

3.  Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts.

Authors:  Alexander Gray; Henric Olsson; Ian H Batty; Larisa Priganica; C Peter Downes
Journal:  Anal Biochem       Date:  2003-02-15       Impact factor: 3.365

4.  Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance.

Authors:  Jose R Bayascas; Stephan Wullschleger; Kei Sakamoto; Juan M García-Martínez; Carol Clacher; David Komander; Daan M F van Aalten; Krishna M Boini; Florian Lang; Christopher Lipina; Lisa Logie; Calum Sutherland; John A Chudek; Janna A van Diepen; Peter J Voshol; John M Lucocq; Dario R Alessi
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

Review 5.  SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Tom Büchse; Gerald Krystal
Journal:  Exp Hematol       Date:  2003-12       Impact factor: 3.084

6.  The phosphoproteome of toll-like receptor-activated macrophages.

Authors:  Gabriele Weintz; Jesper V Olsen; Katja Frühauf; Magdalena Niedzielska; Ido Amit; Jonathan Jantsch; Jörg Mages; Cornelie Frech; Lars Dölken; Matthias Mann; Roland Lang
Journal:  Mol Syst Biol       Date:  2010-06-08       Impact factor: 11.429

7.  The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation.

Authors:  Edward J McManus; Barry J Collins; Peter R Ashby; Alan R Prescott; Victoria Murray-Tait; Laura J Armit; J Simon C Arthur; Dario R Alessi
Journal:  EMBO J       Date:  2004-04-29       Impact factor: 11.598

8.  MK2 Regulates Ras Oncogenesis through Stimulating ROS Production.

Authors:  Yusuke Kobayashi; Xiaomei Qi; Guan Chen
Journal:  Genes Cancer       Date:  2012-07

9.  WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate.

Authors:  Alberto C Vitari; Maria Deak; Barry J Collins; Nick Morrice; Alan R Prescott; Anne Phelan; Sian Humphreys; Dario R Alessi
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

10.  Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).

Authors:  Juan M García-Martínez; Jennifer Moran; Rosemary G Clarke; Alex Gray; Sabina C Cosulich; Christine M Chresta; Dario R Alessi
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

View more
  39 in total

1.  The α-cyclodextrin complex of the Moringa isothiocyanate suppresses lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells through Akt and p38 inhibition.

Authors:  Sabrina Giacoppo; Thangavelu Soundara Rajan; Renato Iori; Patrick Rollin; Placido Bramanti; Emanuela Mazzon
Journal:  Inflamm Res       Date:  2017-03-13       Impact factor: 4.575

2.  Hydroxysafflor yellow A inhibits lipopolysaccharide-induced proliferation and migration of vascular smooth muscle cells via Toll-like receptor-4 pathway.

Authors:  Guoshuai Yang; Xiaoyan Zhou; Tao Chen; Yidong Deng; Dan Yu; Suyue Pan; Yanmin Song
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  A nanobody that recognizes a 14-residue peptide epitope in the E2 ubiquitin-conjugating enzyme UBC6e modulates its activity.

Authors:  Jingjing Ling; Ross W Cheloha; Nicholas McCaul; Zhen-Yu J Sun; Gerhard Wagner; Hidde L Ploegh
Journal:  Mol Immunol       Date:  2019-09-10       Impact factor: 4.407

Review 4.  Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases.

Authors:  Feng Qian; Jing Deng; Gang Wang; Richard D Ye; John W Christman
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

5.  Development of Selective Covalent Janus Kinase 3 Inhibitors.

Authors:  Li Tan; Koshi Akahane; Randall McNally; Kathleen M S E Reyskens; Scott B Ficarro; Suhu Liu; Grit S Herter-Sprie; Shohei Koyama; Michael J Pattison; Katherine Labella; Liv Johannessen; Esra A Akbay; Kwok-Kin Wong; David A Frank; Jarrod A Marto; Thomas A Look; J Simon C Arthur; Michael J Eck; Nathanael S Gray
Journal:  J Med Chem       Date:  2015-08-18       Impact factor: 7.446

6.  A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.

Authors:  Caitlin M Tice; Crystal Tran; Michael L Beshiri; Holly M Nguyen; Adam G Sowalsky; Supreet Agarwal; Keith H Jansson; Qi Yang; Kerry M McGowen; JuanJuan Yin; Aian Neil Alilin; Fatima H Karzai; William L Dahut; Eva Corey; Kathleen Kelly
Journal:  Clin Cancer Res       Date:  2018-05-10       Impact factor: 12.531

Review 7.  mTORC1 and mTORC2 as regulators of cell metabolism in immunity.

Authors:  Monika Linke; Stephanie Deborah Fritsch; Nyamdelger Sukhbaatar; Markus Hengstschläger; Thomas Weichhart
Journal:  FEBS Lett       Date:  2017-06-23       Impact factor: 4.124

Review 8.  Regulation of innate immune cell function by mTOR.

Authors:  Thomas Weichhart; Markus Hengstschläger; Monika Linke
Journal:  Nat Rev Immunol       Date:  2015-10       Impact factor: 53.106

9.  Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide.

Authors:  William T Festuccia; Philippe Pouliot; Inan Bakan; David M Sabatini; Mathieu Laplante
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

Review 10.  The TLR and IL-1 signalling network at a glance.

Authors:  Philip Cohen
Journal:  J Cell Sci       Date:  2014-05-14       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.